These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9587317)

  • 1. Evaluation of the biocompatibility of a nonceramic hydroxyapatite.
    Liu C; Wang W; Shen W; Chen T; Hu L; Chen Z
    J Endod; 1997 Aug; 23(8):490-3. PubMed ID: 9587317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inherent toxicology and biocompatibility of magnesium phosphate bone cement.
    Yu Y; Wang J; Liu C; Zhang B; Chen H; Guo H; Zhong G; Qu W; Jiang S; Huang H
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):496-504. PubMed ID: 20074920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of particle size of hydroxyapatite nanoparticles on its biocompatibility.
    Ding T; Xue Y; Lu H; Huang Z; Sun J
    IEEE Trans Nanobioscience; 2012 Dec; 11(4):336-40. PubMed ID: 22438516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity evaluation of sesamin and episesamin.
    Hori H; Takayanagi T; Kamada Y; Shimoyoshi S; Ono Y; Kitagawa Y; Shibata H; Nagao M; Fujii W; Sakakibara Y
    Mutat Res; 2011 Feb; 719(1-2):21-8. PubMed ID: 20937410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of methyl tertiary butyl ether.
    Zhou W; Yuan D; Huang G; Zhang H; Ye S
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):35-9. PubMed ID: 10905506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity assessment of an energetic propellant compound, 3-nitro-1,2,4-triazol-5-one (NTO).
    Reddy G; Song J; Kirby P; Lent EM; Crouse LC; Johnson MS
    Mutat Res; 2011 Feb; 719(1-2):35-40. PubMed ID: 21094274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay.
    Li PR; Wei JC; Chiu YF; Su HL; Peng FC; Lin JJ
    ACS Appl Mater Interfaces; 2010 Jun; 2(6):1608-13. PubMed ID: 20568705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1993 Dec; 43(12):1253-7. PubMed ID: 8141809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells).
    Gad SC; Sharp KL; Montgomery C; Payne JD; Goodrich GP
    Int J Toxicol; 2012; 31(6):584-94. PubMed ID: 23212452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue response to fast-setting calcium phosphate cement in bone.
    Miyamoto Y; Ishikawa K; Takechi M; Toh T; Yoshida Y; Nagayama M; Kon M; Asaoka K
    J Biomed Mater Res; 1997 Dec; 37(4):457-64. PubMed ID: 9407293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-setting bioactive calcium-magnesium phosphate cement with high strength and degradability for bone regeneration.
    Wu F; Wei J; Guo H; Chen F; Hong H; Liu C
    Acta Biomater; 2008 Nov; 4(6):1873-84. PubMed ID: 18662897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management.
    Warheit DB; Hoke RA; Finlay C; Donner EM; Reed KL; Sayes CM
    Toxicol Lett; 2007 Jul; 171(3):99-110. PubMed ID: 17566673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering.
    Guo H; Su J; Wei J; Kong H; Liu C
    Acta Biomater; 2009 Jan; 5(1):268-78. PubMed ID: 18722167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity study of the new cephalosporin antibiotic cefditoren pivoxil.
    Shindo Y; Hayashi H; Ando M; Tatebayashi T
    Arzneimittelforschung; 1996 Aug; 46(8):815-21. PubMed ID: 9125285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational hazard evaluation of p-bromobenzyl bromide from tests for genotoxicity.
    Sargent EV; Sina JF; Barnum JE; Storer RD; Johnson TE; Galloway SM; Prato MG; Kirsten NN; Naumann BD
    Drug Chem Toxicol; 1999 Nov; 22(4):583-93. PubMed ID: 10536750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotoxicity of a new NanoHA-PA66 root filling material in vitro].
    Ye L; Su Q; Zhou XD; Tan H
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):93-5. PubMed ID: 15190784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of fluor-hydroxyapatite, fluorapatite and hydroxyapatite on colony formation, DNA damage and mutagenicity.
    Jantová S; Theiszová M; Letasiová S; Birosová L; Palou TM
    Mutat Res; 2008 Apr; 652(2):139-44. PubMed ID: 18424173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new porous titanium-nickel alloy: Part 1. Cytotoxicity and genotoxicity evaluation.
    Assad M; Chernyshov A; Leroux MA; Rivard CH
    Biomed Mater Eng; 2002; 12(3):225-37. PubMed ID: 12446938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro degradation, biocompatibility, and in vivo osteogenesis of poly(lactic-co-glycolic acid)/calcium phosphate cement scaffold with unidirectional lamellar pore structure.
    He F; Ye J
    J Biomed Mater Res A; 2012 Dec; 100(12):3239-50. PubMed ID: 22733543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.